Correlation Between Mineralys Therapeutics, and MagnaChip Semiconductor

Can any of the company-specific risk be diversified away by investing in both Mineralys Therapeutics, and MagnaChip Semiconductor at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Mineralys Therapeutics, and MagnaChip Semiconductor into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Mineralys Therapeutics, Common and MagnaChip Semiconductor, you can compare the effects of market volatilities on Mineralys Therapeutics, and MagnaChip Semiconductor and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Mineralys Therapeutics, with a short position of MagnaChip Semiconductor. Check out your portfolio center. Please also check ongoing floating volatility patterns of Mineralys Therapeutics, and MagnaChip Semiconductor.

Diversification Opportunities for Mineralys Therapeutics, and MagnaChip Semiconductor

0.41

Correlation Coefficient

Mineralys Therapeutics,  MagnaChip Semiconductor

Very weak diversification

The 3 months correlation between Mineralys and MagnaChip is 0.41. Overlapping area represents the amount of risk that can be diversified away by holding Mineralys Therapeutics, Common and MagnaChip Semiconductor in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on MagnaChip Semiconductor and Mineralys Therapeutics, is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Mineralys Therapeutics, Common are associated (or correlated) with MagnaChip Semiconductor. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of MagnaChip Semiconductor has no effect on the direction of Mineralys Therapeutics, i.e., Mineralys Therapeutics, and MagnaChip Semiconductor go up and down completely randomly.

Pair Corralation between Mineralys Therapeutics, and MagnaChip Semiconductor

Given the investment horizon of 90 days Mineralys Therapeutics, Common is expected to under-perform the MagnaChip Semiconductor. In addition to that, Mineralys Therapeutics, is 1.54 times more volatile than MagnaChip Semiconductor. It trades about -0.07 of its total potential returns per unit of risk. MagnaChip Semiconductor is currently generating about -0.07 per unit of volatility. If you would invest  480.00  in MagnaChip Semiconductor on October 24, 2024 and sell it today you would lose (72.00) from holding MagnaChip Semiconductor or give up 15.0% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Weak
Accuracy	100.0%
Values	Daily Returns

Mineralys Therapeutics, Common  vs.  MagnaChip Semiconductor

Mineralys Therapeutics,

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Mineralys Therapeutics, Common has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of unsteady performance in the last few months, the Stock's basic indicators remain comparatively stable which may send shares a bit higher in February 2025. The newest uproar may also be a sign of mid-term up-swing for the firm private investors.

MagnaChip Semiconductor

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days MagnaChip Semiconductor has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of weak performance in the last few months, the Stock's basic indicators remain fairly strong which may send shares a bit higher in February 2025. The current disturbance may also be a sign of long term up-swing for the company investors.

Pair Trading with Mineralys Therapeutics, and MagnaChip Semiconductor

The main advantage of trading using opposite Mineralys Therapeutics, and MagnaChip Semiconductor positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Mineralys Therapeutics, position performs unexpectedly, MagnaChip Semiconductor can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in MagnaChip Semiconductor will offset losses from the drop in MagnaChip Semiconductor's long position.

The idea behind Mineralys Therapeutics, Common and MagnaChip Semiconductor pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the USA ETFs module to find actively traded Exchange Traded Funds (ETF) in USA.